COVID-19 Archives | Page 76 of 202 | Be Korea-savvy
S. Korea’s Daily Virus Cases Hit New Record High amid Relaxed Virus Curbs

S. Korea’s Daily Virus Cases Hit New Record High amid Relaxed Virus Curbs

SEOUL, Nov. 18 (Korea Bizwire) — South Korea’s new coronavirus cases hit an all-time high on Thursday since the start of the pandemic amid eased social distancing rules, putting health authorities on alert over further upticks. The country reported a record high of 3,292 new daily cases, including 3,272 local infections, raising the total caseload [...]

New COVID-19 Cases Spike to Second-largest Figure of 3,187

New COVID-19 Cases Spike to Second-largest Figure of 3,187

SEOUL, Nov. 17 (Korea Bizwire) — South Korea’s daily new coronavirus cases spiked to surpass the 3,000 mark Wednesday, just shy of an all-time high, health authorities said, deepening concerns over medical capacity amid the continued surge in critical cases. The country reported 3,187 new COVID-19 cases, including 3,163 local infections, raising the total caseload [...]

Mandatory Virus Tests for Foreign Children Raises Concerns over Xenophobia

Mandatory Virus Tests for Foreign Children Raises Concerns over Xenophobia

SEOUL, Nov. 16 (Korea Bizwire) — The government of the southeastern city of Gimhae has ordered mandatory COVID-19 testing of foreign children registered at the city’s daycare centers, raising concerns of xenophobia and possible rights violations. A government memo obtained by Yonhap News Agency showed that the municipality, located 300 kilometers southeast of Seoul, ordered [...]

Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results

Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results

WALTHAM, Mass., Nov. 15 (Korea Bizwire) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today provided an update on its lead COVID-19 antibody program, ADG20, and reported third quarter 2021 financial results. ADG20 is an investigational monoclonal [...]

New COVID-19 Cases Stay Over 2,000 for 5th Straight Day amid Relaxed Virus Curbs

New COVID-19 Cases Stay Over 2,000 for 5th Straight Day amid Relaxed Virus Curbs

SEOUL, Nov. 14 (Korea Bizwire) — South Korea’s COVID-19 cases stayed above 2,000 for the fifth consecutive day Sunday amid worries over a resurgence of infections, as the country relaxed its social distancing restrictions earlier this month in line with the campaign of “living with COVID-19.” Throughout the previous day, 2,419 new coronavirus cases were [...]